Automated Nerve Graft Analysis via Digital IHC
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for quantitative methods to evaluate the clearance of chondroitin sulfate proteoglycans (CSPGs) from processed nerve grafts, as CSPGs inhibit axonal regeneration and current methods lack accuracy and efficiency.
Innovation Solution
The development of automated methods for histology image analysis that quantify CSPG clearance from processed nerve graft tissue samples by using digital immunohistochemistry (IHC) images, specifically through color deconvolution and pixel intensity analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If automated image analysis methods are implemented, then measurement precision and productivity are improved, but device complexity increases
Solution Approach 1:
The patent replaces manual histology analysis with automated digital image analysis systems. Digital algorithms process histology images to quantify CSPG clearance, substituting human visual inspection and manual measurement with computer-based automated detection and quantification, thereby improving precision while managing complexity through software automation.
Solution Approach 2:
The patent creates digital copies of histology slides for analysis. By scanning physical histology sections into digital image format, the system enables repeated, consistent analysis without handling or degrading the original samples, allowing multiple measurements and algorithmic processing to improve quantification accuracy.
2Loss of time
If automated analysis methods are used, then loss of time is reduced, but device complexity increases
Solution Approach 1:
The automated system enables continuous processing of histology images through algorithmic analysis. Multiple images can be processed sequentially without interruption, and the digital nature of the system allows parallel processing capabilities, significantly reducing total analysis time compared to manual methods while the complexity is managed through standardized software protocols.
3Manufacturing precision
If quantitative analysis of CSPG clearance is implemented, then manufacturing precision is improved, but difficulty of detecting and measuring increases
Solution Approach 1:
The patent utilizes immunohistochemical staining that produces distinct color changes to indicate CSPG presence and clearance. The staining protocol generates visible color differences between treated and untreated tissue regions, which the automated image analysis system detects and quantifies, transforming the difficult-to-measure molecular presence into easily detectable optical signals.
Solution Approach 2:
The patent employs immunohistochemical staining as an intermediary step between the physical nerve graft tissue and the digital measurement system. The staining process uses antibodies that specifically bind to CSPG molecules, creating a detectable signal that bridges the gap between the biological sample and the quantitative analysis, thereby simplifying the measurement process while improving precision.
Data Source
AI summary
The invention provides automated methods for analyzing and quantifying the clearance of chondroitin sulfate proteoglycans (CSPGs) from a processed nerve graft tissue sample.